Lexicon Pharmaceuticals, Inc. (LXRX)

NASDAQ: LXRX · IEX Real-Time Price · USD

1.580

+0.040 (2.60%)

At close: Apr 26, 2024, 4:00 PM

1.619

+0.039 (2.47%)

After-hours: Apr 26, 2024, 6:34 PM EDT

Lexicon Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 1997
Revenue	1.2	0.14	0.3	24	322.07	63.21	91.69	79.26	130.01	22.85	Upgrade
Revenue Growth (YoY)	766.19%	-53.36%	-98.76%	-92.55%	409.54%	-31.06%	15.69%	-39.04%	468.89%	928.53%	Upgrade
Cost of Revenue	0.09	0	0	1.93	3.23	2.49	1.9	0	0	0	Upgrade
Gross Profit	1.12	0.14	0.3	22.07	318.84	60.72	89.79	79.26	130.01	22.85	Upgrade
Selling, General & Admin	113.98	48.08	32.34	47.23	56.84	63.75	66.09	43.16	23.84	19.41	Upgrade
Research & Development	58.89	52.82	55.05	153.62	91.92	100.24	152.22	163.97	95.19	89.28	Upgrade
Other Operating Expenses	0	0	0	-130.99	28.64	0	0	0	3.6	13.1	Upgrade
Operating Expenses	172.87	100.9	87.39	69.87	177.4	164	218.31	207.13	122.62	121.79	Upgrade
Operating Income	-171.75	-100.76	-87.09	-47.8	141.45	-103.28	-128.52	-127.87	7.4	-98.94	Upgrade
Interest Expense / Income	13.1	2.78	0.8	14.54	20.68	20.78	6.98	6.57	6.72	2.25	Upgrade
Other Expense / Income	-7.73	-1.6	-0.13	-3.77	-3.35	-3.51	0.15	-3	5.36	-0.83	Upgrade
Pretax Income	-177.12	-101.94	-87.76	-58.57	124.12	-120.55	-135.65	-131.45	-4.68	-100.36	Upgrade
Income Tax	0	0	0	0	-6.01	0	-12.66	0	0	-0.07	Upgrade
Net Income	-177.12	-101.94	-87.76	-58.57	130.13	-120.55	-122.99	-131.45	-4.68	-100.29	Upgrade
Shares Outstanding (Basic)	221	166	146	111	106	106	105	104	104	76	Upgrade
Shares Outstanding (Diluted)	221	166	146	111	117	106	105	104	104	76	Upgrade
Shares Change	33.43%	13.79%	31.41%	-5.06%	10.32%	0.56%	1.32%	0.26%	35.68%	4.15%	Upgrade
EPS (Basic)	-0.80	-0.62	-0.60	-0.53	1.23	-1.14	-1.17	-1.27	-0.05	-1.31	Upgrade
EPS (Diluted)	-0.80	-0.62	-0.60	-0.53	1.16	-1.14	-1.17	-1.27	-0.05	-1.31	Upgrade
Free Cash Flow	-162.37	-90.18	-88.24	-132.04	113.74	-148.7	-185.62	-175.86	184.2	-73.53	Upgrade
Free Cash Flow Per Share	-0.73	-0.54	-0.61	-1.19	1.07	-1.41	-1.76	-1.69	1.78	-0.96	Upgrade
Gross Margin	92.94%	100.00%	100.00%	91.96%	99.00%	96.06%	97.93%	100.00%	100.00%	100.00%	Upgrade
Operating Margin	-14264.95%	-72489.21%	-29224.83%	-199.21%	43.92%	-163.39%	-140.17%	-161.34%	5.69%	-432.91%	Upgrade
Profit Margin	-14710.88%	-73341.01%	-29448.99%	-244.11%	40.40%	-190.71%	-134.14%	-165.85%	-3.60%	-438.85%	Upgrade
Free Cash Flow Margin	-13485.63%	-64875.54%	-29610.07%	-550.29%	35.31%	-235.25%	-202.45%	-221.89%	141.68%	-321.75%	Upgrade
Effective Tax Rate	-	-	-	-	-4.85%	-	-	-	-	-	Upgrade
EBITDA	-163.46	-98.74	-86.66	-41.1	148.45	-96.09	-125.27	-122.82	2.77	-96.18	Upgrade
EBITDA Margin	-13576.74%	-71033.81%	-29081.88%	-171.27%	46.09%	-152.02%	-136.63%	-154.97%	2.13%	-420.86%	Upgrade
Depreciation & Amortization	0.55	0.43	0.29	2.93	3.65	3.68	3.4	2.06	0.73	1.93	Upgrade
EBIT	-164.02	-99.16	-86.96	-44.03	144.8	-99.77	-128.67	-124.88	2.04	-98.11	Upgrade
EBIT Margin	-13622.76%	-71341.01%	-29179.87%	-183.50%	44.96%	-157.84%	-140.33%	-157.56%	1.57%	-429.29%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).